Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer

Por Fonsatti, Ester, Maio, Michele
Publicado em 2004

Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?

Por Calabrò, Luana, Maio, Michele
Publicado em 2014

Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy

Por Parmiani, Giorgio, Maccalli, Cristina, Maio, Michele
Publicado no Vaccines (Basel) (2015)

Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?

Por Fonsatti, Ester, Di Giacomo, Anna Maria, Maio, Michele
Publicado em 2004

Peptide-based vaccines for cancer therapy

Por Parmiani, Giorgio, Russo, Vincenzo, Maccalli, Cristina, Parolini, Danilo, Rizzo, Nathalie, Maio, Michele
Publicado no Hum Vaccin Immunother (2014)

Cancer Testis Antigens in human melanoma stem cells: expression, distribution and methylation status

Por Sigalotti, Luca, Covre, Alessia, Zabierowski, Susan, Himes, Benjamin, Colizzi, Francesca, Natali, Pier Giorgio, Herlyn, Meenhard, Maio, Michele
Publicado em 2008

Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study

Por Maccalli, Cristina, Giannarelli, Diana, Capocefalo, Filippo, Pilla, Lorenzo, Fonsatti, Ester, Di Giacomo, Anna Maria, Parmiani, Giorgio, Maio, Michele
Publicado no Oncoimmunology (2015)

Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies

Por Sigalotti, Luca, Covre, Alessia, Fratta, Elisabetta, Parisi, Giulia, Colizzi, Francesca, Rizzo, Aurora, Danielli, Riccardo, Nicolay, Hugues JM, Coral, Sandra, Maio, Michele
Publicado em 2010

Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients

Por Sigalotti, Luca, Fratta, Elisabetta, Bidoli, Ettore, Covre, Alessia, Parisi, Giulia, Colizzi, Francesca, Coral, Sandra, Massarut, Samuele, Kirkwood, John M, Maio, Michele
Publicado em 2011

Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients

Por Sigalotti, Luca, Covre, Alessia, Fratta, Elisabetta, Parisi, Giulia, Sonego, Paolo, Colizzi, Francesca, Coral, Sandra, Massarut, Samuele, Kirkwood, John M, Maio, Michele
Publicado em 2012

Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

Por Maccalli, Cristina, Nicolay, Hugues, Capocefalo, Filippo, Fonsatti, Ester, Chiarucci, Carla, Cutaia, Ornella, Giannarelli, Diana, Parmiani, Giorgio, Di Giacomo, Anna Maria, Maio, Michele
Publicado em 2013

The role of BRAF V600 mutation in melanoma

Por Ascierto, Paolo A, Kirkwood, John M, Grob, Jean-Jacques, Simeone, Ester, Grimaldi, Antonio M, Maio, Michele, Palmieri, Giuseppe, Testori, Alessandro, Marincola, Francesco M, Mozzillo, Nicola
Publicado em 2012

Immunomodulatory activity of SGI-110: a basis for novel chemo-immunotherapeutic combinations in cancer treatment

Por Covre, Alessia, Parisi, Giulia, Nicolay, Hugues JMG, Fazio, Carolina, Fonsatti, Ester, Fratta, Elisabetta, Sigalotti, Luca, Taverna, Pietro, Choy, Gavin, Azab, Mohammad, Coral, Sandra, Maio, Michele
Publicado em 2013

The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward

Por Maio, Michele, Nicolay, Hugues JM, Ascierto, Paolo, Belardelli, Filippo, Camerini, Roberto, Colombo, Mario P, Queirolo, Paola, Ridolfi, Ruggero, Russo, Vincenzo, Anzalone, Lucia, Fonsatti, Ester, Parmiani, Giorgio
Publicado em 2008

Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials

Por Wolchok, Jedd D., Weber, Jeffrey S., Hamid, Omid, Lebbé, Celeste, Maio, Michele, Schadendorf, Dirk, de Pril, Veerle, Heller, Kevin, Chen, Tai-Tsang, Ibrahim, Ramy, Hoos, Axel, O'Day, Steven J.
Publicado em 2010

CXCR6, a Newly Defined Biomarker of Tissue-Specific Stem Cell Asymmetric Self-Renewal, Identifies More Aggressive Human Melanoma Cancer Stem Cells

Por Taghizadeh, Rouzbeh, Noh, Minsoo, Huh, Yang Hoon, Ciusani, Emilio, Sigalotti, Luca, Maio, Michele, Arosio, Beatrice, Nicotra, Maria R., Natali, PierGiorgio, Sherley, James L., La Porta, Caterina A. M.
Publicado em 2010

Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma

Por Colombino, Maria, Lissia, Amelia, Capone, Mariaelena, De Giorgi, Vincenzo, Massi, Daniela, Stanganelli, Ignazio, Fonsatti, Ester, Maio, Michele, Botti, Gerardo, Caracò, Corrado, Mozzillo, Nicola, Ascierto, Paolo A, Cossu, Antonio, Palmieri, Giuseppe
Publicado em 2013

The cost of unresectable stage III or stage IV melanoma in Italy

Por Maio Michele, Ascierto Paolo, Testori Alessandro, Ridolfi Ruggero, Bajetta Emilio, Queirolo Paola, Guida Michele, Romanini Antonella, Chiarion-Sileni Vanna, Pigozzo Jacopo, Di Giacomo Anna Maria, Calandriello Mario, Didoni Guido, van Baardewijk Marck, Konto Cyril, Lucioni Carlo
Publicado em 2012-11-01

The cost of unresectable stage III or stage IV melanoma in Italy

Por Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
Publicado em 2012

High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients

Por Logozzi, Mariantonia, De Milito, Angelo, Lugini, Luana, Borghi, Martina, Calabrò, Luana, Spada, Massimo, Perdicchio, Maurizio, Marino, Maria Lucia, Federici, Cristina, Iessi, Elisabetta, Brambilla, Daria, Venturi, Giulietta, Lozupone, Francesco, Santinami, Mario, Huber, Veronica, Maio, Michele, Rivoltini, Licia, Fais, Stefano
Publicado em 2009